Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Olanzapine as a possible treatment of behavioral symptoms in vascular dementia: risks of cerebrovascular events. A controlled, open-label study.

Moretti R, Torre P, Antonello RM, Cattaruzza T, Cazzato G.

J Neurol. 2005 Oct;252(10):1186-93. Epub 2005 Apr 13.

PMID:
15809822
2.

Olanzapine as a possible treatment for anxiety due to vascular dementia: an open study.

Moretti R, Torre P, Antonello RM, Cattaruzza T, Cazzato G, Bava A.

Am J Alzheimers Dis Other Demen. 2004 Mar-Apr;19(2):81-8.

PMID:
15106388
3.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
4.

Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.

Maher AR, Theodore G.

J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. Review.

PMID:
22784311
5.

Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD).

Gareri P, Cotroneo A, Lacava R, Seminara G, Marigliano N, Loiacono A, De Sarro G.

Arch Gerontol Geriatr Suppl. 2004;(9):207-15.

PMID:
15207416
6.

Atypical neuroleptics as a treatment of agitation and anxiety in Alzheimer's disease: risks or benefits.

Moretti R, Torre P, Antonello RM, Pizzolato G.

Expert Rev Neurother. 2006 May;6(5):705-10. Review.

PMID:
16734518
7.

Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: a 24-month follow-up of 68 patients.

Moretti R, Torre P, Antonello RM, Cazzato G, Griggio S, Bava A.

Am J Alzheimers Dis Other Demen. 2003 Jul-Aug;18(4):205-14.

PMID:
12955785
8.

Do atypical antipsychotics cause stroke?

Herrmann N, Lanctôt KL.

CNS Drugs. 2005;19(2):91-103. Review.

PMID:
15697324
10.
11.

A review of treatment-emergent adverse events during olanzapine clinical trials in elderly patients with dementia.

Kryzhanovskaya LA, Jeste DV, Young CA, Polzer JP, Roddy TE, Jansen JF, Carlson JL, Cavazzoni PA.

J Clin Psychiatry. 2006 Jun;67(6):933-45.

PMID:
16848653
12.

Safety profile assessment of risperidone and olanzapine in long-term care patients with dementia.

Martin H, Slyk MP, Deymann S, Cornacchione MJ.

J Am Med Dir Assoc. 2003 Jul-Aug;4(4):183-8. Erratum in: J Am Med Dir Assoc. 2003 Sep-Oct;4(5):290.

PMID:
12837138
13.

Effect of olanzapine on cognition during treatment of behavioral and psychiatric symptoms in patients with dementia: a post-hoc analysis.

Deberdt WG, Siegal A, Ahl J, Meyers AL, Landbloom R.

Int J Geriatr Psychiatry. 2008 Apr;23(4):364-9.

PMID:
17708584
14.

Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia.

Deberdt WG, Dysken MW, Rappaport SA, Feldman PD, Young CA, Hay DP, Lehman DL, Dossenbach M, Degenhardt EK, Breier A.

Am J Geriatr Psychiatry. 2005 Aug;13(8):722-30.

PMID:
16085789
15.

Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

Schneider LS, Dagerman K, Insel PS.

Am J Geriatr Psychiatry. 2006 Mar;14(3):191-210.

PMID:
16505124
16.

Use and safety of antipsychotics in behavioral disorders in elderly people with dementia.

Gareri P, De Fazio P, Manfredi VG, De Sarro G.

J Clin Psychopharmacol. 2014 Feb;34(1):109-23. doi: 10.1097/JCP.0b013e3182a6096e. Review.

PMID:
24158020
17.

Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.

Maher AR, Maglione M, Bagley S, Suttorp M, Hu JH, Ewing B, Wang Z, Timmer M, Sultzer D, Shekelle PG.

JAMA. 2011 Sep 28;306(12):1359-69. doi: 10.1001/jama.2011.1360. Review. Erratum in: JAMA. 2012 Jan 11;307(2):147.

PMID:
21954480
18.

Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer's dementia.

Street JS, Clark WS, Kadam DL, Mitan SJ, Juliar BE, Feldman PD, Breier A.

Int J Geriatr Psychiatry. 2001 Dec;16 Suppl 1:S62-70.

PMID:
11748789
20.

Supplemental Content

Support Center